FindTrial
Sign In

Outcome Of Pulmonary Tuberculosis In Children And Adolescents Treated With Daily Drug Regimen Of Anti Tuberculosis Treatment

CLINICAL OUTCOMES OF DRUG SENSITIVE PULMONARY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS TREATED WITH DAILY DRUG REGIMEN 2 YEARS AFTER COMPLETION OF TREATMENT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/047837
Enrollment
100
Registered
2022-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

Department of Paediatrics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children and adolescents up to 18years of age who completed 6 months of daily drug regimen for drug sensitive pulmonary tuberculosis at least 2 years back as per National Tuberculosis Elimination Programmme.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Proportion of cases showing recurrence of tuberculosis 2 years after completion of treatment with daily drug regimen for drug sensitive pulmonary tuberculosis as per National Tuberculosis Elimination Programme in children and adolescents up to 18 years of ageTimepoint: Recurrence seen after 2 years of completion of treatment once.Time points not applicable. Time poi—

Secondary

MeasureTime frame
1.The proportion of malnutrition 2.Proportion of TB patients aged more 7 years with impaired pulmonary function as measured by spirometryTimepoint: After 2 years of treatment—

Countries

India

Contacts

Public ContactShivanand Hosatti

Maulana Azad Medical College and Lok Nayak Hospital

doctoranuragagarwal@gmail.com9810409623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026